logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Elan Pharmaceuticals, Inc.


USPTO Granted Patents = 202



Trademarks = 10

Forward Citations = 2,160

Loading Chart...
Loading Chart...

271 inventors (with patents filed for the assignee):

goldMedal Andrei William Konradi (49 out of 88 patents)

silverMedal Michael A Pleiss (47 out of 86 patents)

bronzeMedal Christopher Michael Semko (42 out of 58 patents)

4.  Eugene D Thorsett (41 out of 107 patents)

5.  Varghese John (39 out of 89 patents)

6.  Ying-Zi Xu (29 out of 35 patents)

7.  Jay S Tung (27 out of 49 patents)

8.  Darren B Dressen (24 out of 38 patents)

9.  Roy K Hom (21 out of 24 patents)

10.  Francine S Grant (21 out of 38 patents)

11.  Jenifer Lea Smith (21 out of 21 patents)

12.  Sukanto Sinha (19 out of 38 patents)

13.  John P Anderson (16 out of 20 patents)

14.  Lisa Claire McConlogue (14 out of 17 patents)

15.  Frank Stappenbeck (13 out of 14 patents)


Core Competencies:
Hyperuricemia Treatment
Alpha-Synuclein Antibodies
Polymer Conjugates
Polo-Like Kinase Inhibitors
Inflammatory Disease Treatment
VLA-4 Antagonists
Liquid Tumor Therapies
Amyloidogenic Disease Prevention
Cognitive Impairment Treatment
Beta-Secretase Assays
Alzheimer's Disease Diagnosis
Gamma Secretase Inhibitors

202 patents:

1. 8748496 - Methods of treatment of hyperuricemia and associated disease states (2014-06-10),
2. 8673593 - Antibodies to alpha-synuclein (2014-03-18),
3. 8569426 - Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds (2013-10-29),
4. 8541418 - Inhibitors of polo-like kinase (2013-09-24),
5. 8502016 - Genomic alpha synuclein transgenic animal (2013-08-06),
6. 8450363 - Inhibitors of Jun N-terminal kinase (2013-05-28),
7. 8445503 - Inhibitors of polo-like kinase (2013-05-21),
8. 8410115 - Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds (2013-04-02),
9. 8367836 - Pyridinone antagonists of alpha-4 integrins (2013-02-05),
10. 8367688 - Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 (2013-02-05),
11. 8349321 - Immunoglobulin formulation and method of preparation thereof (2013-01-08),
12. 8283358 - N-sulfonamido polycyclic pyrazolyl compounds (2012-10-09),
13. 8269009 - Methods and compositions for treating liquid tumors (2012-09-18),
14. 8268935 - Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds (2012-09-18),
15. 8263063 - Multimeric VLA-4 antagonists comprising polymer moieties (2012-09-11),
Elan Pharmaceuticals, Inc. is a global biotechnology company specializing in neuroscience research and drug development. With a mission to improve the lives of patients suffering from neurological disorders, Elan focuses on discovering and commercializing innovative treatments. The company's dedicated team of scientists and experts leverage cutting-edge technologies to develop therapies for conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Through collaborations and strategic partnerships, Elan endeavors to advance the field of neuroscience and create a positive impact on patients' well-being.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

202 Patents

#8 in South San Francisco, CA

#454 in California

#1,977 in US

#4,072 in the World

...
South San Francisco, CA, United States of America

Elan Pharmaceuticals, Inc.

Forward Citations = 2,160

271 inventors:

goldMedal Andrei William Konradi (49 out of 88 patents)

silverMedal Michael A Pleiss (47 out of 86 patents)

bronzeMedal Christopher Michael Semko (42 out of 58 patents)

4.  Eugene D Thorsett (41 out of 107 patents)

5.  Varghese John (39 out of 89 patents)

Please report any incorrect information to support@idiyas.com
Loading…